In summary, this study elucidated the molecular mechanisms through which SRR inhibits IL-1β-mediated disc degeneration by modulating the TGF-β1/NF-κB pathway, using in vitro and in vivo models. The gene discussed is NFKB1; the disease is intervertebral disk degenerative disorder.